SCHEMBL1542665

SCHEMBL1542665

COc1ccc(CC2=CC(=O)NC2=O)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.56
DAO P14920 1/20 0.46
ALDH1A1 P00352 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
ATM Q13315 2/20 0.44
POLB P06746 2/20 0.44
KMT2A Q03164 4/20 0.43
KDM4E B2RXH2 1/20 0.42
HSP90AA1 P07900 1/20 0.42
LDHA P00338 1/20 0.42
DHFR P00374 1/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 2/20 0.41
MAPT P10636 1/20 0.41
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3677950 0.80 MEN1 (0.51) ALDH1A1KMT2AMEN1MAPT
SCHEMBL9508340 0.78 MAOA (0.35) KMT2AMEN1
SCHEMBL3669619 0.78 CMA1 (0.48) DAOKMT2ADHFRMEN1
SCHEMBL549018 0.75 MAOA (0.35) DAOKMT2AMEN1
SCHEMBL2095593 0.74 CA2 (1.00) CA2ALDH1A1CYP3A4CYP2C9TSHR
SCHEMBL3671509 0.74 AR (0.46) DAOALDH1A1KDM4EHTTMAPT
SCHEMBL3675112 0.74 DAO (0.41) DAOALDH1A1HTTMAPT
SCHEMBL3470062 0.72 CA2 (0.54) CA2DAOALDH1A1CYP3A4CYP2C9
SCHEMBL3673529 0.71 MAPT (0.46) ALDH1A1KDM4EDHFRHTTMAPT
SCHEMBL29449205 0.70 CA2 (0.91) CA2ALDH1A1CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104059013-B 1-aryl-3-azabicyclo [3.1.0] hexane: its preparation method and for treating the purposes of neuropsychiatric disorders 尤西米克斯生物科学公司 2016-06-22 CN disclosed
CN-104059013-A Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: Preparation And Use To Treat Neuropsychiatric Disorders DOV PHARMACEUTICAL INC 2014-09-24 CN disclosed
EP-2307412-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2011-04-13 EP disclosed
WO-2010002956-A2 HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-01-07 WO disclosed